Breaking News
Get 55% Off 0
🔺 What to do when markets are at an all-time high? Find smart bargains, like these.
See Undervalued Stocks
Close

Bausch Health Companies Inc (BVF)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
7.944 +0.015    +0.25%
14:00:59 - Closed. Currency in EUR
  • Volume: 100
  • Bid/Ask: 7.175 / 7.285
  • Day's Range: 7.781 - 7.944
Type:  Equity
Market:  Germany
ISIN:  CA0717341071 
S/N:  A2JQ1X
Bausch Health 7.944 +0.015 +0.25%

BVF Financial Summary

 
A brief financial summary of Bausch Health Companies Inc as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Bausch Health Companies Inc. reported earnings results for the third quarter and nine months ended September 30, 2024. For the third quarter, the company reported revenue was USD 2,510 million compared to USD 2,238 million a year ago. Net loss was USD 85 million compared to USD 378 million a year ago. For the nine months, revenue was USD 7,066 million compared to USD 6,349 million a year ago. Net loss was USD 139 million compared to USD 553 million a year ago.

AnnualQuarterly  
Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

BVF Income Statement

Gross margin TTM 70.87%
Operating margin TTM 18.79%
Net Profit margin TTM -1.88%
Return on Investment TTM 0%
 Total Revenue  Net Income
Period Ending: Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Total Revenue 2510 2403 2153 2408
Gross Profit 1814 1684 1513 1703
Operating Income 544 423 299 507
Net Income -85 10 -64 -39

BVF Balance Sheet

Quick Ratio MRQ 0.62
Current Ratio MRQ 1.19
LT Debt to Equity MRQ 0%
Total Debt to Equity MRQ -1,831.94%
 Total Assets  Total Liabilities
Period Ending: Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Total Assets 26540 26495 26913 27350
Total Liabilities 26782 26722 27087 27432
Total Equity -242 -227 -174 -82

BVF Cash Flow Statement

Cash Flow/Share TTM 3.78
Revenue/Share TTM 25.81
Operating Cash Flow  8.99%
 Cash  Net Change in Cash
Period Ending: Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 405 380 211 390
Cash From Investing Activities -102 -79 -73 -148
Cash From Financing Activities -189 -424 -340 -79
Net Change in Cash 127 -132 -207 182
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BHC Comments

Write your thoughts about Bausch Health Companies Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mohammad Ali
Mohammad Ali Mar 27, 2024 14:41
Saved. See Saved Items.
This comment has already been saved in your Saved Items
depends on quarterly results
David Harrison
David Harrison Mar 02, 2021 15:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
bullish
Cody Tilma
Cody Tilma Feb 26, 2020 14:33
Saved. See Saved Items.
This comment has already been saved in your Saved Items
will look at this again at around $25, bearish till then
Peter Petrossi
Peter Petrossi Feb 19, 2020 11:48
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sorry...who wrote the next comment.
Peter Petrossi
Peter Petrossi Jul 11, 2019 13:10
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sing it! dreaming..... only dreaming. at what point do analyst get banned for 'fake' analysis?
Srinath Gunaratne
Srinath Gunaratne Aug 14, 2016 0:30
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I do not trust analyst target. Last earnings did not meet analyst expectations. May be long term will reach target 90.00. I bought at 29.00 and sold at 35.00. I follow the chart and will buy again below 30.00.
Mohammed Ali
Mohammed Ali Jul 07, 2016 23:37
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Analyst target for VRX is $90 I am in with 50 shares at $36 hoping analyst to be right this time about $90 target So should I be long on this stock ? Please share your comments
Jeremiah Cox
Jeremiah Cox Jul 07, 2016 23:37
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Stay AWAY!!!!! Dangerous. Clinton will hit on Pharma constraints tonight. With 36 you will be ok in the long run, 6% as of now and have a feeling that 4% more is on the way
PAKAWA pakawa
PAKAWA pakawa Jul 07, 2016 23:37
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Jeremiah Cox  . re: "have a feeling", never be emotional about the markets.......it'd hurt you
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email